Effects of a selectively bred novelty-seeking phenotype on the motivation to take cocaine in male and female rats. 2011

Jennifer A Cummings, and Brooke A Gowl, and Christel Westenbroek, and Sarah M Clinton, and Huda Akil, and Jill B Becker
Molecular and Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, MI 48109, USA. jbbecker@umich.edu.

BACKGROUND Gender and enhanced novelty reactivity can predispose certain individuals to drug abuse. Previous research in male and female rats selectively bred for high or low locomotor reactivity to novelty found that bred High Responders (bHRs) acquire cocaine self-administration more rapidly than bred Low Responders (bLRs) and that bHR females in particular self-administered more cocaine than the other groups. The experiments presented here aimed to determine whether an individual's sex and behavioral phenotype interact to affect motivation to take cocaine. METHODS We examined motivation for taking cocaine in two experiments using a range of doses on a progressive ratio (PR) schedule of responding in bHR or bLR males and females. Additionally, we included a measure of continuing to respond in the absence of reinforcement, a feature of addiction that has been recently incorporated into tests of animal models on the basis of the criteria for substance use disorder in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Statistical analyses were performed using PASW Statistics 18.0 software. Data were analyzed using repeated-measures analysis of variance followed by a Bonferroni correction post hoc test when applicable. RESULTS We found sex differences as well as effects of novelty reactivity on the motivation to self-administer cocaine. Specifically, females demonstrated higher breaking points on the PR schedule compared with males, regardless of phenotype, and bHR males and females exhibited higher motivation than bLR animals at a number of the doses studied. CONCLUSIONS An individual's sex continues to be a predisposing factor with respect to drug abuse liability and can be compounded by additional individual differences such as reactivity to novelty.

UI MeSH Term Description Entries

Related Publications

Jennifer A Cummings, and Brooke A Gowl, and Christel Westenbroek, and Sarah M Clinton, and Huda Akil, and Jill B Becker
September 2009, Neuroscience letters,
Jennifer A Cummings, and Brooke A Gowl, and Christel Westenbroek, and Sarah M Clinton, and Huda Akil, and Jill B Becker
September 2008, Pharmacology, biochemistry, and behavior,
Jennifer A Cummings, and Brooke A Gowl, and Christel Westenbroek, and Sarah M Clinton, and Huda Akil, and Jill B Becker
March 2020, Psychopharmacology,
Jennifer A Cummings, and Brooke A Gowl, and Christel Westenbroek, and Sarah M Clinton, and Huda Akil, and Jill B Becker
March 2009, Psychopharmacology,
Jennifer A Cummings, and Brooke A Gowl, and Christel Westenbroek, and Sarah M Clinton, and Huda Akil, and Jill B Becker
November 2007, Pharmacology, biochemistry, and behavior,
Jennifer A Cummings, and Brooke A Gowl, and Christel Westenbroek, and Sarah M Clinton, and Huda Akil, and Jill B Becker
September 2014, Psychopharmacology,
Jennifer A Cummings, and Brooke A Gowl, and Christel Westenbroek, and Sarah M Clinton, and Huda Akil, and Jill B Becker
July 2018, The international journal of neuropsychopharmacology,
Jennifer A Cummings, and Brooke A Gowl, and Christel Westenbroek, and Sarah M Clinton, and Huda Akil, and Jill B Becker
April 2007, Pharmacology, biochemistry, and behavior,
Jennifer A Cummings, and Brooke A Gowl, and Christel Westenbroek, and Sarah M Clinton, and Huda Akil, and Jill B Becker
May 2017, Nature communications,
Jennifer A Cummings, and Brooke A Gowl, and Christel Westenbroek, and Sarah M Clinton, and Huda Akil, and Jill B Becker
September 2020, Physiology & behavior,
Copied contents to your clipboard!